Northwestern Mutual Wealth Management’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
DCM
ACA
DTC
OCA
CC
Northwestern Mutual Wealth Management's DFTX Position: Q1 2026 in Review
Northwestern Mutual Wealth Management reduced its Definium Therapeutics (DFTX) stake by 16% in Q1 2026, selling an estimated $509 and leaving 155 shares worth $2.93K. The position accounts for ﹤0.01% of the portfolio, ranked #3491.
Northwestern Mutual Wealth Management first reported a position in DFTX in Q3 2021 and has held it in 16 quarters since. The position peaked at $4.11K in Q2 2025. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.
- Northwestern Mutual Wealth Management held 155 shares of Definium Therapeutics worth $2.93K as of Q1 2026.
- Northwestern Mutual Wealth Management sold 30 Definium Therapeutics shares in Q1 2026, an estimated $509.
- Definium Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3491 holding.
- Northwestern Mutual Wealth Management first reported a position in Definium Therapeutics in Q3 2021 and has held it in 16 quarters since.
- Northwestern Mutual Wealth Management's Definium Therapeutics position peaked at $4.11K in Q2 2025.
- 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.